Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Illumina (ILMN)
NASDAQ:ILMN
Illumina (ILMN) Stock Price & Analysis
3,990 Followers
ILMN Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$89.00 - $213.12
Previous Close$104.28
Volume3.26M
Average Volume (3M)1.64M
Market Cap
$16.61B
Enterprise Value$18.78B
Total Cash (Recent Filing)$6.00M
Total Debt (Recent Filing)$2.18B
Price to Earnings (P/E)―
Beta1.47
Next Earnings
Aug 08, 2024EPS Estimate
$0.09Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-8.15
Shares Outstanding159,300,000
10 Day Avg. Volume1,819,556
30 Day Avg. Volume1,639,841
Standard Deviation0.12
R-Squared0.29
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)77.76
Price to Sales (P/S)3.69
Price to Cash Flow (P/CF)18.00
P/FCF Ratio19.80
Enterprise Value/Market CapN/A
Enterprise Value/Revenue4.17
Enterprise Value/Gross Profit6.84
Enterprise Value/Ebitda-647.65
Forecast
1Y Price Target
$152.85Price Target Upside46.58% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering16
Illumina News
PremiumMarket News
SPY ETF Update, 5/31/2024 
PremiumMarket News
QQQ ETF Update, 5/30/2024 
PremiumMarket News
SPY ETF Update, 5/23/2024 
PremiumMarket News
QQQ ETF Update, 5/22/2024
PremiumMarket News
SPY ETF Update, 5/21/2024 
PremiumMarket News
QQQ ETF Update, 5/20/2024 
PremiumMarket News
QQQ ETF Update, 5/16/2024 Bulls Say, Bears Say
Bulls Say
Corporate ActionsILMN's expected distribution of a majority of GRAIL shares in a spinoff could unlock value for existing investors.
Financial PerformanceGRAIL is now expected to burn less cash, with a reduction in operational expenses and a positive growth trajectory in U.S. Galleri sales.
Strategic DevelopmentsThe early implementation pilot for GRAIL presents an opportunity for earlier revenue streams before the broader rollout.
Bears Say
Corporate GovernanceSurprise CFO change adds another wrinkle and this transition introduces another risk in the medium term for the business, as the company is already navigating significant management turnover in recent quarters.
Financial StabilityILMN has seen the departure of multiple top executives in the past year, which raises concerns about corporate stability.
Market ChallengesChallenges such as CapEx softness and competition are likely to continue, affecting the companies' performance.
---
Ownership Overview
1.83% Insiders
31.18% Mutual Funds
59.23% Other Institutional Investors
7.76% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
ILMN FAQ
What was Illumina’s price range in the past 12 months?
Illumina lowest stock price was $89.00 and its highest was $213.12 in the past 12 months.
What is Illumina’s market cap?
Currently, no data Available
When is Illumina’s upcoming earnings report date?
Illumina’s upcoming earnings report date is Aug 08, 2024 which is in 67 days.
How were Illumina’s earnings last quarter?
Illumina released its earnings results on May 02, 2024. The company reported $0.09 earnings per share for the quarter, beating the consensus estimate of $0.043 by $0.047.
Is Illumina overvalued?
According to Wall Street analysts Illumina’s price is currently Undervalued.
Does Illumina pay dividends?
Illumina does not currently pay dividends.
What is Illumina’s EPS estimate?
Illumina’s EPS estimate is $0.09.
How many shares outstanding does Illumina have?
Illumina has 159,300,000 shares outstanding.
What happened to Illumina’s price movement after its last earnings report?
Illumina reported an EPS of $0.09 in its last earnings report, beating expectations of $0.043. Following the earnings report the stock price went down -4.887%.
Which hedge fund is a major shareholder of Illumina?
Among the largest hedge funds holding Illumina’s share is Guardcap Asset Management Ltd. It holds Illumina’s shares valued at 284M.
---
Illumina Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$152.85 (46.58% Upside)
$152.85 (46.58% Upside)
Blogger Sentiment
Bullish
ILMN Sentiment 71%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Decreased
By 612.5K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Positive
Last 7 Days ▲ 0.6%
Last 30 Days ▲ 0.7%
Last 30 Days ▲ 0.7%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-46.97%
12-Months-Change
Fundamentals
Return on Equity
-20.76%
Trailing 12-Months
Asset Growth
-14.99%
Trailing 12-Months
Company Description
Illumina
Incorporated in 1998, Illumina, Inc. is a California-based company which develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. Its products and services serve customers in the research, clinical and applied markets, and enable the adoption of a variety of genomic solutions. The company's products include microarray scanners, sequencing reagents, and onsite training selector. Its services include sequencing and microarray services; proactive instrument monitoring; and instrument services, training, and consulting.
---
ILMN Company Deck
---
ILMN Earnings Call
Q1 2024
0:00 / 0:00
---
ILMN Revenue Breakdown
68.45% Consumables
15.92% Service and other revenue
15.63% Instruments
---
ILMN Stock 12 Month Forecast
Average Price Target
$152.85
▲(46.58% Upside)
Technical Analysis
BioMarin Pharmaceutical
―
Vertex Pharmaceuticals
―
Alnylam Pharma
―
Ionis Pharmaceuticals
―
Best Analysts Covering ILMN
1 Year
1 Year Success Rate
16/20 ratings generated profit
1 Year Average Return
+19.95%
reiterated a sell rating 2 months ago
Copying Luke Sergott's trades and holding each position for 1 Year would result in 80.00% of your transactions generating a profit, with an average return of +19.95% per trade.
---